Related references
Note: Only part of the references are listed.The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2 A Randomized Clinical Trial
George W. Sledge et al.
JAMA ONCOLOGY (2020)
Leptomeningeal carcinomatosis in patients with breast cancer
Maria Alice Franzoi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis
Mario Giuliano et al.
LANCET ONCOLOGY (2019)
Abemaciclib for the treatment of brain metastases (BM) secondary to hormone receptor positive (HR+), HER2 negative breast cancer.
Sara M. Tolaney et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours
E. Le Rhun et al.
ANNALS OF ONCOLOGY (2017)
Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis
Aki Morikawa et al.
CLINICAL BREAST CANCER (2017)
Leptomeningeal carcinomatosis as the primary presentation of relapse in breast cancer
Keith Sacco et al.
ONCOLOGY LETTERS (2016)
Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors
Amita Patnaik et al.
CANCER DISCOVERY (2016)
Leptomeningeal disease and breast cancer: the importance of tumor subtype
Sausan Abouharb et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis
S. Yust-Katz et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival
Anna Niwinska et al.
MEDICAL ONCOLOGY (2013)
Prognostic factors and clinical features in patients with leptominengeal metastases from breast cancer: a single center experience
Icro Meattini et al.
JOURNAL OF CHEMOTHERAPY (2012)
Survival of breast cancer patients with meningeal carcinomatosis
H. Gauthier et al.
ANNALS OF ONCOLOGY (2010)
Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis
Kadri Altundag et al.
CANCER (2007)
Share Paper
